Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Disease; Flu”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00996970
What this trial is testing

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

Who this might be right for
InfluenzaHIV Infections
Henry M. Jackson Foundation for the Advancement of Military Medicine 132
Not applicableLooking for participantsNCT04579588
What this trial is testing

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Who this might be right for
Corona Virus InfectionFlu VaccineImmunity
Stanford University 230
Not applicableStudy completedNCT03478254
What this trial is testing

Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1).

Who this might be right for
Type 1 Diabetes Mellitus
Jesús Moreno Fernández 300
Not applicableStudy completedNCT02907645
What this trial is testing

Influenza Vaccine Randomized Educational Trial: Adult

Who this might be right for
VaccinationInfluenza
Columbia University 222
Testing effectiveness (Phase 2)Study completedNCT02423577
What this trial is testing

Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain

Who this might be right for
Influenza
Autoimmune Technologies, LLC 79
Early research (Phase 1)Study completedNCT01258530
What this trial is testing

Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers

Who this might be right for
Influenza, Human
GlaxoSmithKline 28
Large-scale testing (Phase 3)Study completedNCT01773928
What this trial is testing

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 1,928
Post-approval studies (Phase 4)Study completedNCT07710586
What this trial is testing

Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine in China

Who this might be right for
Influenza Vaccine
Ab&B Bio-tech Co., Ltd.JS 3,105
Post-approval studies (Phase 4)UnknownNCT02762851
What this trial is testing

Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)

Who this might be right for
Heart FailureInfluenza
McMaster University 5,000
Not applicableUnknownNCT01465477
What this trial is testing

Influenza Vaccination in Fibromyalgia Patients

Who this might be right for
Fibromyalgia Syndrome
Tel-Aviv Sourasky Medical Center 80
Not applicableStudy completedNCT01651754
What this trial is testing

Humoral and Cellular Immune Responses After Influenza Vaccination in Patients With Postcancer Fatigue and in Patients With Chronic Fatigue Syndrome

Who this might be right for
Postcancer FatigueChronic Fatigue Syndrome
Radboud University Medical Center 72
Testing effectiveness (Phase 2)Study completedNCT01052402
What this trial is testing

Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents

Who this might be right for
Influenza, Avian
Alachua Government Services, Inc. 684
Post-approval studies (Phase 4)Study completedNCT00735475
What this trial is testing

Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine

Who this might be right for
Influenza
Seqirus 1,268
Large-scale testing (Phase 3)Study completedNCT05317767
What this trial is testing

The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years.

Who this might be right for
Influenza
St. Petersburg Research Institute of Vaccines and Sera 600
Large-scale testing (Phase 3)Study completedNCT00929331
What this trial is testing

Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years

Who this might be right for
Influenza, Human
GlaxoSmithKline 110
Not applicableStudy completedNCT01007201
What this trial is testing

Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population

Who this might be right for
Influenza
Adimmune Corporation 183
Large-scale testing (Phase 3)Study completedNCT02839330
What this trial is testing

Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Who this might be right for
Avian Influenza
Seqirus 3,196
Testing effectiveness (Phase 2)Study completedNCT01227967
What this trial is testing

Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 881
Post-approval studies (Phase 4)Study completedNCT02723812
What this trial is testing

Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old

Who this might be right for
Influenza, Human
Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products 120
Early research (Phase 1)Study completedNCT00408109
What this trial is testing

Safety Study of Avian Flu Vaccine

Who this might be right for
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus A+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 45
Next Page